Integrated Filing — IndAS



General information about company
Scrip Code 523261
NSE Symbol VENKEYS
MSEI Symbol NOTLISTED
ISIN INE388A01010
Name of company Venky's (India) Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 08-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 08-Aug-2025   10:30:00
End date and time of board meeting 08-Aug-2025   12:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification
Whether the company has any related party?
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.
Whether the company is a high value debt listed entity according to regulation 15 (1A)?
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?
Latest Date on which RPT policy is updated
Indicate Company website link for updated RPT policy of the Company
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 8658300000
Other income 116900000
Total income 8775200000
2 Expenses
(a) Cost of materials consumed 5530800000
(b) Purchases of stock-in-trade 790200000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 213100000
(d) Employee benefit expense 632300000
(e) Finance costs 42900000
(f) Depreciation, depletion and amortisation expense 92100000
(f) Other Expenses
1 Purchase of bearer biological assets 150200000 150200000
2 Other Expenses 1105900000 1105900000
Total other expenses 1256100000
Total expenses 8557500000
3 Total profit before exceptional items and tax 217700000
4 Exceptional items 0
5 Total profit before tax 217700000
6 Tax expense
7 Current tax 50000000
8 Deferred tax 9400000
9 Total tax expenses 59400000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 158300000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 158300000
17 Other comprehensive income net of taxes 0
18 Total Comprehensive Income for the period 158300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 140900000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 11.24
Diluted earnings (loss) per share from continuing operations 11.24
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 11.24
Diluted earnings (loss) per share from continuing and discontinued operations 11.24
24 Debt equity ratio 0
25 Debt service coverage ratio 0
26 Interest service coverage ratio 0
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Poultry and Poultry products 4756600000 4756600000
2 Animal Health Products 969800000 969800000
3 Oilseed 3180200000 3180200000
Total Segment Revenue 8906600000
Less: Inter segment revenue 248300000 248300000
Revenue from operations 8658300000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Poultry and Poultry products -56600000 -56600000
2 Animal Health Products 231800000 231800000
3 Oilseed 100500000 100500000
Total Profit before tax 275700000
i. Finance cost 42900000 42900000
ii. Other Unallocable Expenditure net off Unallocable income 15100000 15100000
Profit before tax 217700000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Poultry and Poultry products 8060400000 8060400000
2 Animal Health Products 2749500000 2749500000
3 Oilseed 6585400000 6585400000
Total Segment Asset 17395300000 17395300000
Un-allocable Assets 3516200000 3516200000
Net Segment Asset 20911500000 20911500000
4 Segment Liabilities
Segment Liabilities
1 Poultry and Poultry products 2539100000 2539100000
2 Animal Health Products 664300000 664300000
3 Oilseed 564500000 564500000
Total Segment Liabilities 3767900000 3767900000
Un-allocable Liabilities 2229600000 2229600000
Net Segment Liabilities 5997500000 5997500000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income 0





Details of Impact of Audit Qualification
Whether results are audited or unaudited
Declaration of unmodified opinion or statement on impact of audit qualification
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto